Nicola Redfern | Director
NJ Redfern Ltd.

Nicola Redfern is a highly experienced industry professional in the field of cell and gene therapies and has had a career focussed mainly in oncology, haematology and rare diseases. She has worked in house for multiple pharmaceutical and biotech companies and, as the Director of NJ Redfern Ltd, brings a wealth of knowledge and expertise to the organisations she works alongside. She set up in 2022 to consult, coach, and collaborate with other organisations in the areas of early launch planning and market access, and has a keen interest in PPIE. With a proven track record of success in developing and implementing innovative therapeutic strategies and operationalising them, Nicola is dedicated to advancing the field of regenerative medicine and ensuring new innovations become a choice for those who might benefit from them.

At Advanced Therapies UK 2027, Nicola will share her insights during one of the panels and is looking forward to meeting familiar and new faces.